Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro does not work straight away in the sense most people hope for. The 2.5mg starting dose exists to help your body adjust, not to produce weight loss, and meaningful appetite changes usually take several weeks to build. That said, some people notice reduced hunger within the first week or two — the biology begins shifting earlier than the scales reflect. These are prescription-only medicines; a prescriber assesses whether they are right for you before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people starting Mounjaro expect the first pen to feel different. When it doesn't, the worry sets in, is it working, is it real, is there something wrong? That anxiety is understandable, and it's based on a misconception worth correcting upfront.
The 2.5mg starting dose is not a therapeutic dose. Its job is to introduce tirzepatide to your system gradually, reducing the likelihood of the nausea and digestive discomfort that come with GLP-1 receptor activation. The prescriber will typically keep you at 2.5mg for four weeks before any increase. Some people feel mild appetite suppression during this phase; others notice nothing much at all. Both responses are normal.
What's actually happening beneath that quiet surface is more interesting. Tirzepatide activates both the GIP and GLP-1 receptors involved in appetite signalling and blood-sugar regulation, and it slows gastric emptying, how quickly food leaves your stomach. Those mechanisms take time to produce a measurable shift, especially at the lowest dose. The mechanism behind how Mounjaro works explains why the dual-receptor approach is the reason tirzepatide tends to outperform single-pathway medicines as the dose climbs, but that climb takes months, not days. If you're wondering whether Mounjaro starts working straight away, the short answer is that the early weeks are about adjustment rather than immediate results. Worth sitting with that expectation from the start.
Most people report the first meaningful change in appetite somewhere between weeks two and six, often after their first or second dose increase. Feeling comfortably full on a smaller portion, losing interest in snacking, or simply not thinking about food as much, these signals tend to arrive before the scales move noticeably.
Weight on the scales lags behind appetite change for a practical reason: the body takes time to translate reduced calorie intake into measurable fat loss, and early fluctuations (water, digestive contents, timing of weighing) can mask genuine progress. A useful check is how your clothes fit and how your hunger patterns have shifted, not just a single number on a morning weigh-in.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, randomised 2,539 adults and ran for 72 weeks. Participants at the 15mg maintenance dose saw average body-weight reduction of around 20–21% over that period. That figure accumulated gradually across the full treatment course, it was not front-loaded into the early weeks. If you're curious whether tirzepatide produces faster early results than the named brand, the honest answer is: the active ingredient is identical, and the timeline is the same.
The gastrointestinal effects that many people notice in the first few weeks (nausea, loose stools, feeling uncomfortably full, occasional burping) are a direct consequence of tirzepatide slowing gastric emptying and activating GLP-1 receptors in the gut. They are not pleasant, but they are broadly predictable and tend to ease as the body adjusts, usually within days to a couple of weeks at each dose level.
The NHS tirzepatide medicines page lists the common side effects and notes that most are gastrointestinal. Eating smaller meals, staying well-hydrated, and avoiding very fatty or rich food in the early weeks all help. If symptoms are severe or persistent, the prescriber needs to know, titration can be slowed. Getting medical help promptly matters for anything severe: intense stomach pain that spreads to the back in particular warrants urgent attention, as pancreatitis is a known but uncommon risk with GLP-1 medicines.
For a broader look at the Mounjaro treatment itself, including how it's supplied and what a full course involves, the overview page covers the practicalities in one place. And if you've wondered about an unrelated early side effect (whether Mounjaro can cause thrush, for instance) that has its own dedicated answer.
A reasonable frame for the first 12 weeks is this: month one is adjustment, month two is where appetite change becomes reliable, month three is where weight loss tends to become visible to others as well as the scales. That is a generalisation (individual responses vary, and some people move faster or slower) but it reflects the typical arc seen in clinical practice.
Stopping early because the first four weeks felt uneventful is the most common way to miss what Mounjaro can actually do. The same applies in reverse: feeling little effect at 2.5mg does not mean you need a higher dose immediately; the dose-increase schedule exists for safety reasons, and skipping steps creates more GI problems, not faster results. It's also worth understanding whether you can come straight off Mounjaro when the time comes, as stopping abruptly carries its own considerations that are worth planning for in advance.
If you're weighing up the cost alongside the expected timeline, the treatment page sets out how pricing at nume works, one transparent amount that covers consultation, prescription and delivery, with a real prescriber reviewing your case on the same day. There are no subscriptions; every repeat order is reviewed before anything goes out. Your first pen arrives via DPD the next working day in plain, unbranded packaging, tracked to your door.
For anyone transferring from another provider or considering starting for the first time, our clinical team reviews every consultation personally. If you have questions before starting, contact us directly or check the FAQs for common queries already answered.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.